Synthesis, Characterization, and Biological Activity of New 4‘‐Functionalized Bis‐Terpyridine Ruthenium(II) Complexes: Anti‐Inflammatory Activity Advances
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400680 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Mohamed M Elnagar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Electrochemistry, Ulm University, Albert-Einstein-Allee 47, 89081, Ulm, Germany. Hauptthemen laut MEDLINE: Ruthenium, Coordination Complexes, Pyridines, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ruthenium complexes incorporating 2,2′ : 6′,2′′‐terpyridine ligands have emerged as promising candidates due to their versatile biological activities including DNA‐binding, anti‐inflammatory, antimicrobial, and anticancer properties. In this study, three new 4′‐functionalized bis(terpyridine) Ru(II) complexes were synthesized. These complexes feature one ligand as 4‐(2,2′ : 6′,2′′‐terpyridine‐4′‐yl) benzoic acid and the second ligand as either 4′‐(2‐thienyl)‐2,2′ : 6′,2′′‐terpyridine, 4′‐(3,4‐dimethoxyphenyl)‐2,2′ : 6′,2′′‐terpyridine, or 4′‐(4‐dimethylaminophenyl)‐2,2′ : 6′,2′′‐terpyridine. Besides the chemical characterization by 1 H and 13 C NMR, mass spectrometry, and absorption and emission spectroscopy, the complexes were tested for their biological activity as anti‐inflammatory, anticancer, and antimicrobial agents. Moreover, the toxicity of the Ru(II) complexes was assessed and benchmarked against diclofenac potassium and ibuprofen using a haemolysis assay. Biological evaluations demonstrate that these ruthenium complexes exhibit promising therapeutic potential with reduced haemolytic activity compared to standard drugs. They demonstrate substantial anti‐inflammatory effects through inhibition of albumin denaturation along with moderate cytotoxicity against cancer cell lines and broad‐spectrum antimicrobial activity. These findings highlight the multifaceted biomedical applications of 4′‐functionalized bis(terpyridine) Ru(II) complexes, suggesting their potential for further development as effective and safe therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Electrochemistry, Ulm University, Albert-Einstein-Allee 47, 89081, Ulm, Germany.
- Department of Inorganic Chemistry, National Research Centre, 33 El Bohouth St. (former Tahrir St.), 12622, Dokki, Giza, Egypt.
- Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, P.O. Box 30, Giza, Egypt.
- Department of Microbial Chemistry, National Research Centre, 33 El Bohouth St. (former Tahrir St.), 12622, Dokki, Giza, Egypt.
- Division of Pharmaceutical and Drug Industries, Department of the Chemistry of Natural and Microbial Products, National Research Centre, El Buhouth Street, Dokki, Cairo, 12622, Egypt.
ORCID-Profile: Mohamed M Elnagar
Zitieren
APA
Elnagar, M. M., Abou-El-Sherbini, K. S., Samir, S., Sharmoukh, W., Abdel-Aziz, M. S., & Shaker, Y. M. (2025). Synthesis, Characterization, and Biological Activity of New 4‘‐Functionalized Bis‐Terpyridine Ruthenium(II) Complexes: Anti‐Inflammatory Activity Advances. ChemMedChem. https://doi.org/10.1002/cmdc.202400680
Vancouver
Elnagar MM, Abou-El-Sherbini KS, Samir S, Sharmoukh W, Abdel-Aziz MS, Shaker YM. Synthesis, Characterization, and Biological Activity of New 4‘‐Functionalized Bis‐Terpyridine Ruthenium(II) Complexes: Anti‐Inflammatory Activity Advances. ChemMedChem. 2025. doi:10.1002/cmdc.202400680
BibTeX
@article{Elnagar2025,
author = {Elnagar, Mohamed M and Abou-El-Sherbini, Khaled S and Samir, Safia and Sharmoukh, Walid and Abdel-Aziz, Mohamed S and Shaker, Yasser M},
title = {Synthesis, Characterization, and Biological Activity of New 4‘‐Functionalized Bis‐Terpyridine Ruthenium(II) Complexes: Anti‐Inflammatory Activity Advances},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400680}
}
EUVIMED